You just read:

DalCor's Dalcetrapib Demonstrates Genotype-Dependent Effects on Cholesterol Efflux and Inflammation in Data Published by The Montreal Heart Institute in Circulation: Cardiovascular Genetics

News provided by

DalCor Pharmaceuticals

Jul 18, 2016, 09:18 ET